Home › Therapeutic areas › Oncology › Cutaneous Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma (5 companies)
Companies with an active program in Cutaneous Squamous Cell Carcinoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| DRTS | Alpha Tau Medical | Oncology | 1 | Phase 2 | $1.12B | 6 |
| BCAX | Bicara Therapeutics | Oncology | 1 | Phase 2 | $637M | 4 |
| FBIO | Fortress Biotech | DermatologyHematology+4 Rare | 1 | Approved | $61.4M | 16 |
| PHIO | Phio Pharmaceuticals | Oncology | 1 | Phase 1 | $8.6M | 4 |
| REPL | Replimune Group | Oncology | 1 | Approved | $1.87B | 5 |
No companies match.